Procoralan 5 mg film-coated tablets

Illustration Procoralan 5 mg film-coated tablets
Substance(s) Ivabradine
Admission country United Kingdom
Manufacturer Les Laboratoires Servier
Narcotic No
ATC Code C01EB17
Pharmacological group Other cardiac preparations

Authorisation holder

Les Laboratoires Servier

Drugs with same active substance

Drug Substance(s) Authorisation holder
Corlentor 5 mg film-coated tablets Ivabradine Les Laboratoires Servier
Corlentor 7.5 mg film-coated tablets Ivabradine Les Laboratoires Servier
Procoralan 7.5 mg film-coated tablets Ivabradine Les Laboratoires Servier

Patient’s Leaflet

What is it and how is it used?

Procoralan (ivabradine) is a heart medicine used to treat stable angina pectoris which causes chest pain.
It is used in adult patients who do not tolerate or cannot take heart medicines called beta-blockers. It is also used in combination with beta-blockers in adult patients whose condition is not fully controlled with a beta-blocker and whose heart rate is too high (over 60 beats per minute).

About stable angina pectoris (usually referred to as ?angina?):
Stable angina is a heart disease which happens when the heart does not receive enough oxygen. It usually appears between 40 and 50 years of age. The most common symptom of angina is chest pain or discomfort. Angina is more likely to happen when the heart beats faster in situations such as exercise, emotion, exposure to the cold or after eating. This increase in heart rate can cause the chest pain in people who suffer from angina.

How does Procoralan work?
Procoralan mainly works by reducing the heart rate by a few beats per minute. This lowers the heart?s need for oxygen especially in the situations when an angina attack is more likely to happen. In this way Procoralan helps to control and reduce the number of angina attacks.

Ad

What do you have to consider before using it?

Do not take Procoralan
  • if you are allergic (hypersensitive) to ivabradine or any of the other ingredients of Procoralan (see ?further information? for a list of all ingredients);
  • if your resting heart rate before treatment is too slow (below 60 beats per minute);
  • if you are suffering from cardiogenic shock (a heart condition treated in hospital);
  • if you suffer from a heart rhythm disorder;
  • if you are having a heart attack;
  • if you suffer from very low blood pressure;
  • if you suffer from unstable angina (a severe form in which chest pain occurs very frequently and with or without exertion);
  • if you suffer from severe heart failure (when your heart fails to work properly);
  • if you have a pacemaker;
  • if you suffer from severe liver problems;
  • if you are already taking medicines for the treatment of fungal infections (such as ketoconazole, itraconazole), macrolide antibiotics (such as josamycin, clarithromycin, telithromycin or erythromycin given orally), medicines to treat HIV infections (such as nelfinavir, ritonavir) or nefazodone (medicine to treat depression) (see ?Taking other medicines?);
  • if you are pregnant;
  • if you are breast-feeding.
Take special care with Procoralan
  • if you suffer from heart rhythm disorders (such as irregular heartbeat, palpitation, increase in chest pain) or sustained atrial fibrillation (a type of irregular heartbeat),
  • if you have symptoms such as tiredness, dizziness or shortness of breath (this could mean that your heart is slowing down too much),
  • if you have had a recent stroke (cerebral attack),
  • if you suffer from mild to moderate low blood pressure,
  • if you suffer from chronic heart failure (when your heart fails to work properly),
  • if you suffer from chronic eye retinal disease,
  • if you suffer from moderate liver problems,
  • if you suffer from severe renal problems. If any of the above applies to you, talk straight away to your doctor before or while taking Procoralan.

Children
Procoralan is not intended for use in children and adolescents younger than 18 years.

Taking other medicines
Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.

Make sure to tell your doctor if you are taking any of the following medicines, as a dose adjustment of Procoralan or monitoring should be required:

  • diltiazem, verapamil (used for high blood pressure or angina pectoris)
  • fluconazole (an antifungal medicine)
  • rifampicin (an antibiotic)
  • barbiturates (for difficult sleeping or epilepsy)
  • phenytoin (for epilepsy)
  • Hypericum perforatum or St John?s Wort (herbal treatment for depression)
  • QT prolonging medicines to treat either heart rhythm disorders or other conditions :
  • quinidine, disopyramide, ibutilide, sotalol, amiodarone (to treat heart rhythm disorders)
  • bepridil (to treat angina pectoris)
  • certain types of medicines to treat anxiety, schizophrenia or other psychoses (such as pimozide, ziprasidone, sertindole)
  • anti-malarial medicines (such as mefloquine or halofantrine)
  • intravenous erythromycin (an antibiotic)
  • pentamidine (an antiparasitic medicine)
  • cisapride (against the gastro-oesophageal reflux)

Taking Procoralan with food and drink

Limit your consumption of grapefruit juice during treatment with Procoralan.

Pregnancy and breast-feeding

Do not take Procoralan if you are pregnant or planning a pregnancy (see ?Do not take Procoralan?).If you are pregnant and have taken Procoralan, talk to your doctor.
Do not take Procoralan if you are breast-feeding (see ?Do not take Procoralan?).

Ask your doctor or pharmacist for advice before taking any medicine.

Driving and using machines
Procoralan may cause temporary luminous visual phenomena (a temporary brightness in the field of vision, see ?Possible side effects?). If this happens to you, be careful when driving or using machines at times when there could be sudden changes in light intensity, especially when driving at night.

Important information about some of the ingredients of Procoralan

Procoralan contains lactose. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.

Ad

How is it used?

Always take Procoralan exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure. The usual recommended starting dose is one tablet of Procoralan 5 mg twice daily increasing if necessary to one tablet of Procoralan 7.5 mg twice daily. Your doctor will decide the right dose for you. The usual dose is one tablet in the morning and one tablet in the evening. In some cases (e.g. if you are elderly), your doctor may prescribe half the dose i.e., one half 5 mg tablet of Procoralan 5 mg (corresponding to 2.5 mg ivabradine) in the morning and one half 5 mg tablet in the evening.
Procoralan should be taken during meals.

If you take more Procoralan than you should:
A large dose of Procoralan could make you feel breathless or tired because your heart slows down too much. If this happens, contact your doctor immediately.

If you forget to take Procoralan:
If you forget to take a dose of Procoralan, take the next dose at the usual time. Do not take a double dose to make up for the forgotten dose.
The calendar printed on the blister containing the tablets should help you remember when you last took a tablet of Procoralan.

If you stop taking Procoralan:

As the treatment for angina is usually life-long, you should discuss with your doctor before stopping this medicinal product.
If you think that the effect of Procoralan is too strong or too weak, talk to your doctor or pharmacist.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

Ad

What are possible side effects?

Like all medicines, Procoralan can cause side effects, although not everybody gets them.

The frequency of possible side effects listed below is defined using the following convention: very common (affects more than 1 user in 10)
common (affects 1 to 10 users in 100)
uncommon (affects 1 to 10 users in 1,000)
rare (affects 1 to 10 users in 10,000)
very rare (affects less than 1 user in 10,000)
not known (frequency cannot be estimated from the available data)

Very common:
Luminous visual phenomena (brief moments of increased brightness, most often caused by sudden changes in light intensity).

Common:
Modification in the heart functioning (the symptoms are a slowing down of the heart rate), abnormal perception of heartbeat, headache, dizziness and blurred vision.

Uncommon:

Palpitations and cardiac extra beats, feeling sick (nausea), constipation, diarrhoea, spinning sensation (vertigo), difficulty breathing (dyspnoea), muscle cramps and changes in laboratory parameters: high blood levels of uric acid, an excess of eosinophils (a type of white blood cell) and elevated creatinine in blood (a breakdown product of muscle).

Not known:

Itching, skin rash, skin reddening, low blood pressure, feeling of faintness, syncope.

If any of the side effects gets serious or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.

Ad

How should it be stored?

Keep out of the reach and sight of children.

Do not use Procoralan after the expiry date which is stated on the carton and blister after ?EXP?. The expiry date refers to the last day of that month.

This medicine does not require any special storage conditions.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.

Ad

Further information

What Procoralan contains
  • The active substance is ivabradine (as hydrochloride). Procoralan 5 mg: one film-coated tablet contains 5 mg ivabradine (equivalent to 5.390 mg ivabradine as hydrochloride). Procoralan 7.5 mg: one film-coated tablet contains 7.5 mg ivabradine (equivalent to 8.085 mg ivabradine as hydrochloride).
  • The other ingredients in the tablet core are: lactose monohydrate, magnesium stearate (E 470 B), maize starch, maltodextrin, colloidal anhydrous silica (E 551), and in the tablet coating: hypromellose (E 464), titanium dioxide (E 171), macrogol 6000, glycerol (E 422), magnesium stearate (E 470 B), yellow iron oxide (E 172), red iron oxide (E 172).

What Procoralan looks like and contents of the pack

Procoralan 5 mg tablets are salmon-coloured, oblong film-coated tablets scored on both sides, engraved with ?5? on one face and on the other.
Procoralan 7.5 mg tablets are salmon-coloured, triangular, film-coated tablets engraved with ?7.5? on one face and on the other.

The tablets are available in calendar packs (Aluminium/PVC blisters) of 14, 28, 56, 84, 98, 100 or 112 tablets.
Not all pack sizes may be marketed.

Marketing Authorisation Holder and Manufacturer:

Marketing Authorisation Holder:

Les Laboratoires Servier
22 rue Garnier
92200 Neuilly sur Seine - France

Manufacturer:
Les Laboratoires Servier Industrie
905 route de Saran
45520 Gidy ? France

Servier (Ireland) Industries Ltd

Gorey Road

Arklow - Co. Wicklow ? Ireland

Przedsiebiorstwo Farmaceutyczne ANPHARM S.A.

ul. Annopol 6B ? 03-236 Warszawa ? Poland

Akmon farmacevtske industrije d.o.o.

Industrijska cesta 1J

1290 Grosuplje ? Slovenia

For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder.

BelgiëBelgiqueBelgien S.A. Servier Benelux N.V. TélTel 32 02 529 43 11 LuxembourgLuxemburg S.A. Servier Benelux N.V. TélTel 32 02 529 43 11

. 359 2 921 57 00 Magyarország Servier Hungaria Kft. Tel. 36 1 238 77 99

eská republika Servier s.r.o. Tel 420 222 118 111 Malta GALEPHARMA Ltd Tel 356 21 247 082

Danmark Servier Danmark AS Tlf 45 36 44 22 60 Nederland Servier Nederland Farma B.V. Tel 31 071 5246700

Deutschland Servier Deutschland GmbH Tel 49 089 57095 01 Norge Servier Danmark AS Tlf 45 36 44 22 60

Eesti CentralPharma Communications OÜ Tel 372 640 00 07 Österreich Servier Austria GmbH Tel 43 1 524 39 99

30 210 939 1000 Polska Servier Polska SP. Z O.O. Tel. 48 0 22 594 90 00

España Laboratorios Servier S.L. Tel 34 91 748 96 30 Portugal Servier Portugal, Lda Tel 351 21 312 20 00

France Les Laboratoires Servier Tél 33 01 55 72 60 00 România Servier Pharma SRL Tel 4 021 528 52 80

Ireland Servier Laboratories Ireland Ltd. Tel 353 01 6638110 Slovenija Servier Pharma d.o.o. Tel 386 01563 48 11

Slovenská republika Servier Slovensko spol. s r.o. Tel 421 02 5920 41 11 Ísland Servier Laboratories co Icepharma hf Sími 354 540 8000

Italia Servier Italia S.p.A. Tel 39 06 669081 SuomiFinland Servier Finland Oy PuhTel 358 09 279 80 80

.. 357 22741741 Sverige Servier Sverige AB Tel 46 85 225 08 00

United Kingdom Servier Laboratories Ltd Tel 44 01 753 666409 Latvija SIA Servier Latvia Tel 371 67502039

Lietuva
UAB ?SERVIER PHARMA?
Tel: +370 (5) 2 63 86 28

This leaflet was last approved in

Ad

Substance(s) Ivabradine
Admission country United Kingdom
Manufacturer Les Laboratoires Servier
Narcotic No
ATC Code C01EB17
Pharmacological group Other cardiac preparations

Share

Ad

Your personal medicine assistent

afgis-Qualitätslogo mit Ablauf Jahr/Monat: Mit einem Klick auf das Logo öffnet sich ein neues Bildschirmfenster mit Informationen über medikamio GmbH & Co KG und sein/ihr Internet-Angebot: medikamio.com/ This website is certified by Health On the Net Foundation. Click to verify.
Drugs

Search our database for drugs, sorted from A-Z with their effects and ingredients.

Substances

All substances with their common uses, chemical components and medical products which contain them.

Diseases

Causes, symptoms and treatment for the most common diseases and injuries.

The contents shown do not replace the original package insert of the medicinal product, especially with regard to dosage and effect of the individual products. We cannot assume any liability for the correctness of the data, as the data was partly converted automatically. A doctor should always be consulted for diagnoses and other health questions. Further information on this topic can be found here.